Premium
Manifesting carrier of Becker muscular dystrophy (BMD): clinical and recombinant DNA studies
Author(s) -
Ionasescu V. V.,
Searby Ch. C.,
Ionasescu R.
Publication year - 1989
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1989.tb03821.x
Subject(s) - muscular dystrophy , muscle biopsy , recombinant dna , dystrophin , creatine kinase , dystrophy , medicine , endocrinology , genetics , gene , biology , biopsy , pathology
— We studied a Becker muscular dystrophy (BMD) family with a manifesting carrier. Proximal muscle weakness, pseudohypertrophy of the calves, significantly elevated serum creatine kinase and dystrophic alterations in the muscle biopsy were the characteristic phenotypical features of this manifesting carrier. The recombinant DNA study showed a recombinant chromosome with a crossover between pERT 87–8 and pERT J‐Bir in the manifesting carrier. However, the proximal part of the short arm of her X chromosome was identical to a non‐manifesting carrier (her sister) and to her affected brother. For this reason, we assumed the BMD mutation was proximal to the crossover. The dystrophin cDNA probes showed no deletion of DMD/BMD gene.